On the public citation graph
Rhabdomyolysis during concomitant ticagrelor and rosuvastatin: A breast cancer resistance protein‐mediated drug interaction?
0 signed · 46 inferred · view as graph
Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.
Is this your work? Sign in with ORCID and put your name on the
claims that are yours.
Reference health. See whether every reference in this work resolves to a
known work and none has been retracted — and get a dated CiteStamped
badge you can embed.
What this work says
Outgoing claims: the papers this work cites, builds on, or argues with.
inferredcites →https://doi.org/10.1002/cpt.2557openalex-snapshot
The Clinical Pharmacogenetics Implementation Consortium Guideline for SLCO1B1 , ABCG2 , and CYP2C9 genotypes and Statin‐Associated Musculoskeletal Symptoms
inferredcites →https://doi.org/10.1007/s00228-012-1369-4openalex-snapshot
Pharmacokinetic interaction studies of co-administration of ticagrelor and atorvastatin or simvastatin in healthy volunteers
inferredcites →https://doi.org/10.1016/j.clpt.2006.09.003openalex-snapshot
Drug interactions with lipid-lowering drugs: Mechanisms and clinical relevance
inferredcites →https://doi.org/10.1016/j.ejps.2022.106246openalex-snapshot
Functional in vitro characterization of SLCO1B1 variants and simulation of the clinical pharmacokinetic impact of impaired OATP1B1 function.
inferredcites →https://doi.org/10.1016/j.xphs.2017.03.027openalex-snapshot
Rosuvastatin Pharmacokinetics in Asian and White Subjects Wild Type for Both OATP1B1 and BCRP Under Control and Inhibited Conditions
inferredcites →https://doi.org/10.1038/clpt.2009.197openalex-snapshot
Transporter Pharmacogenetics and Statin Toxicity
inferredcites →https://doi.org/10.1038/clpt.2012.163openalex-snapshot
Understanding the Critical Disposition Pathways of Statins to Assess Drug–Drug Interaction Risk During Drug Development: It's Not Just About OATP1B1
inferredcites →https://doi.org/10.1038/sj.clpt.6100220openalex-snapshot
Different Effects of SLCO1B1 Polymorphism on the Pharmacokinetics of Atorvastatin and Rosuvastatin
inferredcites →https://doi.org/10.1053/j.gastro.2006.02.034openalex-snapshot
Drug and Bile Acid Transporters in Rosuvastatin Hepatic Uptake: Function, Expression, and Pharmacogenetics
inferredcites →https://doi.org/10.1056/nejmoa0801936openalex-snapshot
SLCO1B1 Variants and Statin-Induced Myopathy — A Genomewide Study
inferredcites →https://doi.org/10.1097/01.npr.0000794540.96561.51openalex-snapshot
Acute kidney injury and rhabdomyolysis due to ticagrelor and rosuvastatin
inferredcites →https://doi.org/10.1111/bcp.12377openalex-snapshot
Pitavastatin is a more sensitive and selective organic anion‐transporting polypeptide 1B clinical probe than rosuvastatin
inferredcites →https://doi.org/10.1111/bcp.15485openalex-snapshot
A comprehensive pharmacogenomic study indicates roles for SLCO1B1, ABCG2 and SLCO2B1 in rosuvastatin pharmacokinetics
inferredcites →https://doi.org/10.1111/bcpt.13035openalex-snapshot
Rosuvastatin‐Induced Rhabdomyolysis – Possible Role of Ticagrelor and Patients’ Pharmacogenetic Profile
inferredcites →https://doi.org/10.1111/bph.15540openalex-snapshot
THE CONCISE GUIDE TO PHARMACOLOGY 2021/22: Nuclear hormone receptors
inferredcites →https://doi.org/10.1111/cts.12809openalex-snapshot
Febuxostat, But Not Allopurinol, Markedly Raises the Plasma Concentrations of the Breast Cancer Resistance Protein Substrate Rosuvastatin
inferredcites →https://doi.org/10.1124/dmd.121.000406openalex-snapshot
Comparative Hepatic and Intestinal Metabolism and Pharmacodynamics of Statins
inferredcites →https://doi.org/10.1124/jpet.119.257600openalex-snapshot
Quantitative Contribution of Six Major Transporters to the Hepatic Uptake of Drugs: “SLC-Phenotyping” Using Primary Human Hepatocytes
inferredcites →https://doi.org/10.1136/bcr-2022-249294openalex-snapshot
Acute kidney injury post coronary angioplasty
inferredcites →https://doi.org/10.1177/0018578720928262openalex-snapshot
The Interaction Between Rosuvastatin and Ticagrelor Leading to Rhabdomyolysis: A Case Report and Narrative Review
inferredcites →https://doi.org/10.12691/ajmcr-7-12-9openalex-snapshot
Ticagrelor and Statin Interaction Induces Rhabdomyolysis and Acute Renal Failure: Case reports and Scoping Review
inferredcites →https://doi.org/10.1371/journal.pone.0273292openalex-snapshot
Changes in lipoproteins associated with lipid-lowering and antiplatelet strategies in patients with acute myocardial infarction
inferredcites →https://doi.org/10.14744/anatoljcardiol.2017.8200openalex-snapshot
Ticagrelor-induced acute kidney injury can increase serum concentration of statin and lead to concurrence of rhabdomyolysis
inferredcites →https://doi.org/10.2147/pgpm.s228709openalex-snapshot
A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions
inferredcites →https://doi.org/10.2217/pgs.09.85openalex-snapshot
Different Effects of the ABCG2 C.421C>A SNP on the Pharmacokinetics of Fluvastatin, Pravastatin and Simvastatin
inferredcites →https://doi.org/10.7326/l20-0549openalex-snapshot
Rosuvastatin Myotoxicity After Starting Canagliflozin Treatment: A Case Report
inferredcites →https://doi.org/10.7759/cureus.1633openalex-snapshot
A Unique Case of Drug Interaction between Ticagrelor and Statin Leading to Acute Renal Failure
inferredcites →https://doi.org/10.7759/cureus.20035openalex-snapshot
A Rare Case of Delayed Onset Multi-Drug Interaction Resulting in Rhabdomyolysis in a 66-Year-Old Male
What points at this work
Incoming claims: where this work appears in other papers’ reference lists and arguments.
inferred← citeshttps://doi.org/10.2139/ssrn.4832604openalex-extracted
Medication -Induced Rhabdomyolysis: A Disproportionality Analysis of the FAERS Data
inferred← citeshttps://doi.org/10.1002/cpt.3067openalex-snapshot
Ticagrelor Increases Exposure to the Breast Cancer Resistance Protein Substrate Rosuvastatin
inferred← citeshttps://doi.org/10.1002/cpt.3384openalex-snapshot
Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4
inferred← citeshttps://doi.org/10.1007/s10557-026-07871-wopenalex-snapshot
Possible clinical drug interactions between ticagrelor and concomitant medications: for adverse drug event monitoring in real-world
inferred← citeshttps://doi.org/10.1007/s40262-025-01489-1openalex-snapshot
Ticagrelor is Associated with Increased Rosuvastatin Blood Concentrations in Patients who have had a Myocardial Infarction
inferred← citeshttps://doi.org/10.1007/s40278-023-35492-7openalex-snapshot
Rosuvastatin/ticagrelor interaction
inferred← citeshttps://doi.org/10.1016/bs.seda.2024.07.020openalex-snapshot
Side effects of anti-lipid medications
inferred← citeshttps://doi.org/10.1016/j.biopha.2023.115393openalex-snapshot
Role of the NLRP3 inflammasome in gynecological disease
inferred← citeshttps://doi.org/10.1016/j.ejps.2025.107073openalex-snapshot
Comparative uptake of statins by hepatic organic anion transporting polypeptides
inferred← citeshttps://doi.org/10.1016/j.ejps.2026.107662openalex-snapshot
Novel inhibitors of BCRP found among drugs used in the treatment of cancer
inferred← citeshttps://doi.org/10.1080/15376516.2023.2262568openalex-snapshot
Differential effects of OATP2B1 on statin accumulation and toxicity in a beta cell model
inferred← citeshttps://doi.org/10.1111/bcpt.13928openalex-snapshot
Inhibition of efflux transporters by poly ADP‐ribose polymerase inhibitors
inferred← citeshttps://doi.org/10.1111/bcpt.70271openalex-snapshot
Using Pharmacovigilance Data for Signal Detection of Drug Interactions for Rosuvastatin
inferred← citeshttps://doi.org/10.1186/s40246-024-00579-8openalex-snapshot
Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity
inferred← citeshttps://doi.org/10.31083/ijp46518openalex-snapshot
Effects of Ticagrelor on the Absorption and Metabolism of Imatinib in Rats
inferred← citeshttps://doi.org/10.3138/cpj-24-0105openalex-snapshot
Management of a patient with a ticagrelor–rosuvastatin interaction: An algorithm-based tool kit for pharmacists
inferred← citeshttps://doi.org/10.6084/m9.figshare.25132101openalex-snapshot
Additional file 1 of Solanidine is a sensitive and specific dietary biomarker for CYP2D6 activity
inferred← citeshttps://doi.org/10.7759/cureus.117125openalex-snapshot
Severe Rhabdomyolysis and Acute Kidney Injury Following Rosuvastatin Reinitiation During Ticagrelor Therapy: A Case Report and Literature Review
Editorial review for independent work. ICSAC — the Institute for Complexity
Science and Advanced Computing — runs a structured editorial panel for researchers
publishing outside journals, and publishes on CiteStamp rails. Submission is free
and goes through ORCID: icsacinstitute.org/submit.